Lewy Body Pathology Linked to Cerebral Amyloid Angiopathy in Alzheimer’s Disease Patients
Alzheimer’s disease and Lewy body pathologies impact risk factors for cerebral amyloid angiopathy and should be considered when assessing patients’ candidacy for anti-amyloid therapy.